research proposal lung cancer

This proposal highlights a strategy to delineate the precise patient population to which to apply these agents making use of an unparalleled collection of patient samples and patient-derived models for validation. ... * * This project was awarded the LCRF William C. Rippe Award for Distinguished Research in Lung Cancer, acknowledging the ...

Lung cancer research grant mechanisms open for submission. NEW YORK, NY (January 11, 2024) - Today, the Lung Cancer Research Foundation (LCRF) announced that its 2024 funding mechanisms are now open for submission. LCRF's four core funding mechanisms are aimed at furthering its commitment to funding investigators who are dedicated to finding solutions to the most pressing issues in lung ...

The proposal must include studies in patients and/or patient samples with oncogene-driven lung cancer. A proposal that is associated with a clinical trial either as part of the project or planned as a result of the research will be favorably looked upon. ... LCRF Leading Edge Research Grant Program. Lung cancer continues to be the number one ...

Lung cancer continues to be the number one cause of cancer deaths worldwide, accounting for an estimated 127,070 deaths annually in the United States alone1. Despite being the most common cancer killer for both men and women, lung cancer research remains critically underfunded. To help close this gap and improve outcomes,

Technical questions: contact proposal CENTRAL at [email protected] or 1-800-875-2562. Questions on the Awards and Grants program: email [email protected]. Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more. The goals of the Awards and Grants Program are to foster ...

"Soliciting research proposals that seek to cure oncogenic-driven lung cancer is a step in the right direction to improve survivorship." "Getting the best minds to team up to address the complexities that lead to resistance in oncogenic-driven lung cancer will be exciting," says Dr. Antoinette Wozniak, LCRF's Chief Scientific Officer.

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Today, the Lung Cancer Research Foundation (LCRF) announced that its 2024 funding mechanisms are now open for submission. LCRF's four core funding ...

Request for Proposals: 2021 LCRF Pilot Grant Program 1. Program Summary Lung cancer continues to be the number one cause of cancer deaths worldwide, accounting for an estimated 136,000 deaths annually in the United States alone1. Despite being the most common cancer killer of both men and women, lung cancer research remains critically underfunded.

The American Lung Association is committed to funding lung cancer research. As part of our Awards and Grants Program, a large part of funds goes toward research on lung cancer prevention, treatment and quality of life. The primary goal of this lung cancer research program is simple: improve and save lives.

The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.

Pre-proposals are due by Friday, July 23. Projects will be selected by a joint steering committee for funding up to a maximum of $250,000 (inclusive of indirect costs) per year, with the opportunity to renew for a second year. Research Focus. Proposals should be focused on preventing, intercepting, or curing lung cancer at early stages and ...

Research Focus. Proposals should be focused on preventing, intercepting, or curing lung cancer at early stages and should consider the concepts that lung cancer is often caused by chronic exposure to respiratory carcinogens that produce cellular/genomic damage, chronic inflammation, and alterations in innate/adaptive immunity — all may ...

The NCI-sponsored National Lung Screening Trial (NLST) showed that low-dose CT scans can be used to screen for lung cancer in people with a history of heavy smoking. Using this screening can decrease their risk of dying from lung cancer. Now researchers are looking for ways to refine CT screening to better predict whether cancer is present.

Lung cancer is the leading cause of cancer mortality in the United States, accounting for 21% of all deaths. 1 This year, more than 238,340 U.S. men and women will be diagnosed with lung cancer, and over 127,000 will die from the disease. Lung cancer is generally diagnosed at an advanced, incurable stage because patients often lack signs and symptoms in the early stages of the disease.

Pre-proposals are due by Friday, July 30. Projects will be selected by a joint steering committee for funding up to a maximum of $250,000 (inclusive of indirect costs) per year, with the opportunity to renew for a second year. Research Focus. Proposals should be focused on preventing, intercepting, or curing lung cancer at early stages and ...

Anyone can get lung cancer. Lung cancer is the leading cause of cancer mortality in the United States, accounting for 22% of all deaths. 1. In 2021, more than 235,000 U.S. men and women will be diagnosed with lung cancer, and over 131,800 will die from the disease. 1. Lung cancer incidence and mortality is highest in African Americans compared ...

NCI Funding Opportunities by Research Topic. AI research is supported by a wide variety of grant and contract programs across NCI. Research projects in basic cancer biology are supported and coordinated through the Division of Cancer Biology (DCB). Behavioral research in cancer prevention and control is supported by the Division of Cancer ...

Abstract. In the realm of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) therapy with tyrosine kinase inhibitors (TKI), addressing optimal treatment for uncommon EGFR mutations like G719X in exon 18, S768I in exon 20, and L861Q in exon 21 remains a pivotal yet challenging frontier. Contrary to the well-established efficacy of EGFR-TKIs in common ...

Lung cancer research grant mechanisms open for submission. NEW YORK, NY (February 9, 2023) - The Lung Cancer Research Foundation (LCRF) announced today that its 2023 funding mechanisms are now open for submission. Following an unprecedented number of research grants awarded in a single grant cycle in 2022, LCRF has opened its 2023 Requests for Proposals, aimed at furthering its commitment to ...

Lung cancer is the leading cause of cancer death globally, accounting for over a quarter of all cancer-related deaths. Non-small cell lung cancer (NSCLC) is the most common form, making up roughly ...

Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Authors: ... The data will be provided following review and approval of a research proposal and Statistical Analysis Plan and execution of a Data Sharing Agreement. For approved requests the data will be accessible for ...

Groups request proposals for Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancer. New York, NY (January 11, 2024) - The Lung Cancer Research Foundation announced today that, in partnership with the International Association for the Study of Lung Cancer, submissions are being accepted for the $2.5 million, four-year award, titled IASLC-LCRF Team ...

The LCRF Research Grant on Understanding Resistance in Lung Cancer will focus on understanding resistance and support research projects with an emphasis on characterizing, identifying, treating, overcoming, or preventing resistance to therapies in lung tumor cells, tissues, mouse models, or patients. This mechanism will address important ...

The primary research objective of the UK trial is to determine whether lung cancer screening using low-dose Spiral CT reduces mortality from lung cancer. To address this issue a randomized controlled trial of Spiral CT vs. no screening in smokers, 60 years and over, is proposed, with lung cancer mortality as the primary end-point.

The objectives of this interest group are to: To create and harmonize lung-specific phenotypes and relevant clinical data. To facilitate the progress of approved COMETS project proposals focused on lung disease. To facilitate new collaborative efforts resulting in additional COMETS project proposals.

Lung cancer is the most common cause of cancer-related death worldwide, with an estimated 1.8 million deaths each year [].Non-small cell lung cancer (NSCLC) is the major pathological type of lung cancer, consisting of approximately 85% of all lung cancer cases [].Among the various stages, Stage III NSCLC with N2 mediastinal nodal involvement, represents a heterogeneous patient population who ...

"Lung tissue samples can now be analyzed in minutes by our computer program to provide fairly accurate predictions of whether their cancer will return, predictions that are better than current ...

June 10, 2024. Progress in Lung Cancer Screening Adoption. Ilana B. Richman, MD, MHS 1,2; Cary P. Gross, MD 1,2,3. Author Affiliations Article Information. 1 Department of Medicine, Yale School of Medicine, New Haven, Connecticut. 2 Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven ...

A universal nomenclature of the anatomic extent of lung cancer has been critical for individual patient care as well as research advances. As progress occurs, new details emerge that need to be included in a refined system that aligns with contemporary clinical management issues. The 9th edition TNM classification of lung cancer, which is scheduled to take effect in January of 2025, addresses ...

Research Progress on Pathogenesis of Lung Cancer and Prevention Discussion. December 2023. Highlights in Science Engineering and Technology 74:421-427. December 2023. 74:421-427. DOI: 10.54097 ...